Year |
Citation |
Score |
2007 |
Nichols LA, Chen Y, Colella TA, Bennett CL, Clausen BE, Engelhard VH. Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. Journal of Immunology (Baltimore, Md. : 1950). 179: 993-1003. PMID 17617591 DOI: 10.4049/Jimmunol.179.2.993 |
0.556 |
|
2002 |
Engelhard VH, Bullock TN, Colella TA, Sheasley SL, Mullins DW. Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunological Reviews. 188: 136-46. PMID 12445287 DOI: 10.1034/J.1600-065X.2002.18812.X |
0.765 |
|
2001 |
Bullock TN, Mullins DW, Colella TA, Engelhard VH. Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 167: 5824-31. PMID 11698456 DOI: 10.4049/Jimmunol.167.10.5824 |
0.741 |
|
2001 |
Mullins DW, Bullock TN, Colella TA, Robila VV, Engelhard VH. Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 167: 4853-60. PMID 11673489 DOI: 10.4049/Jimmunol.167.9.4853 |
0.703 |
|
2000 |
Engelhard VH, Bullock TN, Colella TA, Mullins DW. Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use. Cancer Journal (Sudbury, Mass.). 6: S272-80. PMID 10874498 |
0.767 |
|
2000 |
Slingluff CL, Colella TA, Thompson L, Graham DD, Skipper JC, Caldwell J, Brinckerhoff L, Kittlesen DJ, Deacon DH, Oei C, Harthun NL, Huczko EL, Hunt DF, Darrow TL, Engelhard VH. Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens. Cancer Immunology, Immunotherapy : Cii. 48: 661-72. PMID 10752474 DOI: 10.1007/S002620050015 |
0.732 |
|
2000 |
Colella TA, Bullock TN, Russell LB, Mullins DW, Overwijk WW, Luckey CJ, Pierce RA, Restifo NP, Engelhard VH. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy. The Journal of Experimental Medicine. 191: 1221-32. PMID 10748239 DOI: 10.1084/Jem.191.7.1221 |
0.765 |
|
2000 |
Bullock TN, Colella TA, Engelhard VH. The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 164: 2354-61. PMID 10679070 DOI: 10.4049/Jimmunol.164.5.2354 |
0.704 |
|
1998 |
Luckey CJ, King GM, Marto JA, Venketeswaran S, Maier BF, Crotzer VL, Colella TA, Shabanowitz J, Hunt DF, Engelhard VH. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. Journal of Immunology (Baltimore, Md. : 1950). 161: 112-21. PMID 9647214 |
0.7 |
|
1998 |
Kittlesen DJ, Thompson LW, Gulden PH, Skipper JC, Colella TA, Shabanowitz J, Hunt DF, Engelhard VH, Slingluff CL, Shabanowitz JA. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. Journal of Immunology (Baltimore, Md. : 1950). 160: 2099-106. PMID 9498746 |
0.701 |
|
1996 |
Slingluff CL, Graham DD, Skipper J, Kittlesen D, Deacon DH, Colella TA, Harthun NL, Huczko EL, Darrow TL, Innes DJ, Golden W, Engelhard VH. Immunologic Escape Variant (IEV) Melanomas with Normal MHC Expression and Antigen Processing Lack Multiple Melanocytic Differentiation Antigens Journal of Immunotherapy. 19: 460. DOI: 10.1097/00002371-199611000-00027 |
0.627 |
|
1996 |
Kittlesen D, Skipper J, Hendrickson R, Colella T, Gulden P, Hunt D, Engelhard V, Slingluff C. Melanoma Patient CTL REcognize HLA-A3 and HLA-A1 Restricted Epitopes Derived From the Melanocyte Differentiation Antigens Pmel-17/gp100 and Tyrosinase Journal of Immunotherapy. 19: 460. DOI: 10.1097/00002371-199611000-00025 |
0.566 |
|
Show low-probability matches. |